Susquehanna International Group, LLP Molecular Templates, Inc. Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.33 - $12.0 $3,966 - $144,228	12,019 New	12,019 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.81 - $3.43 $51,433 - $217,798	63,498 Added 311.6%	83,876 $76,000
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $9,843 - $20,067	-2,921 Reduced 12.54%	20,378 $80,000
Q3 2021 Nov 15, 2021	BUY	$5.78 - $7.86 $134,668 - $183,130	23,299 New	23,299 $156,000
Q2 2021 Aug 11, 2021	SELL	$7.82 - $12.44 $516,495 - $821,637	-66,048 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.33 - $14.05 $366,715 - $552,235	39,305 Added 146.97%	66,048 $834,000
Q4 2020 Feb 16, 2021	BUY	$8.48 - $12.23 $226,780 - $327,066	26,743 New	26,743 $251,000
Q3 2019 Nov 14, 2019	SELL	$4.6 - $8.46 $54,169 - $99,624	-11,776 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$5.83 - $8.42 $6,488 - $9,371	1,113 Added 10.44%	11,776 $98,000
Q2 2019 Aug 14, 2019	BUY	$5.83 - $8.42 $62,165 - $89,782	10,663 New	10,663 $89,000
Q2 2018 Aug 14, 2018	SELL	$5.19 - $9.71 $240,857 - $450,621	-46,408 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.0 - $12.96 $371,264 - $601,447	46,408 New	46,408 $371,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.